Mechanistically, its action is not only due to direct apoptosis induction but also due to immunosuppressive myeloid cell depletion and inhibition of interleukin 6 (IL-6)/IL-23/IL-17-mediated pro-tumor inflammation (65). The gene discussed is IL17A; the disease is neoplasm.